| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 40.495 | 40.283 | 39.404 | 39.182 | 39.899 | 39.142 | 38.274 | 40.582 | 41.188 | 44.385 |
| Total Income - EUR | 40.527 | 40.293 | 57.844 | 41.043 | 41.854 | 39.904 | 38.631 | 40.837 | 41.355 | 57.514 |
| Total Expenses - EUR | 39.029 | 41.441 | 59.637 | 38.858 | 37.064 | 40.162 | 38.746 | 38.807 | 39.864 | 50.401 |
| Gross Profit/Loss - EUR | 1.499 | -1.148 | -1.793 | 2.185 | 4.790 | -258 | -115 | 2.030 | 1.491 | 7.114 |
| Net Profit/Loss - EUR | 283 | -1.551 | -2.771 | 1.793 | 4.450 | -547 | -421 | 1.691 | 1.140 | 5.372 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Diagen Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 21.203 | 15.263 | 28.007 | 22.417 | 17.006 | 12.542 | 7.075 | 1.996 | 0 | 41.524 |
| Current Assets | 73.566 | 69.183 | 67.625 | 64.648 | 46.972 | 32.420 | 10.298 | 6.155 | 6.250 | 7.558 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 68.947 | 66.166 | 63.327 | 59.415 | 42.184 | 24.981 | 3.190 | 3.443 | 3.432 | 4.254 |
| Cash | 4.619 | 3.017 | 4.298 | 5.233 | 4.787 | 7.440 | 7.108 | 2.712 | 2.818 | 3.304 |
| Shareholders Funds | 6.735 | 230 | -2.544 | -704 | 3.760 | 1.107 | 661 | 2.354 | 3.486 | 8.839 |
| Social Capital | 1.125 | 1.559 | 1.532 | 1.504 | 1.475 | 1.447 | 1.415 | 1.419 | 1.415 | 1.407 |
| Debts | 88.141 | 84.754 | 98.257 | 87.833 | 60.695 | 43.894 | 17.167 | 6.297 | 3.262 | 41.389 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7210 - 7210" | |||||||||
| CAEN Financial Year |
7219
|
|||||||||
Comments - Diagen Srl